These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38267841)

  • 21. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
    Vogler MA; Teppler H; Gelman R; Valentine F; Lederman MM; Pomerantz RJ; Pollard RB; Cherng DW; Gonzalez CJ; Squires KE; Frank I; Mildvan D; Mahon LF; Schock B;
    J Acquir Immune Defic Syndr; 2004 May; 36(1):576-87. PubMed ID: 15097300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients.
    Lu L; Li X; Liu X; Qiu Z; Han Y; Song X; Li Y; Li X; Cao W; Lv W; Dou Z; Li T
    Aging (Albany NY); 2022 Dec; 14(23):9647-9667. PubMed ID: 36490352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters.
    Guo FP; Li YJ; Qiu ZF; Lv W; Han Y; Xie J; Li YL; Song XJ; Du SS; Mehraj V; Li TS; Routy JP
    Chin Med J (Engl); 2016 Nov; 129(22):2683-2690. PubMed ID: 27824000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.
    Soria A; Trabattoni D; Squillace N; Rainone V; Gnudi F; Clerici M; Gori A; Bandera A
    PLoS One; 2015; 10(2):e0117118. PubMed ID: 25671649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Level of CD4
    Xia H; Jiang W; Zhang X; Qin L; Su B; Li Z; Sun J; Zhang Y; Zhang T; Lu X; Wu H
    Front Immunol; 2018; 9():616. PubMed ID: 29636753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV.
    Luo Z; Health SL; Li M; Yang H; Wu Y; Collins M; Deeks SG; Martin JN; Scott A; Jiang W
    EBioMedicine; 2022 Jun; 80():104037. PubMed ID: 35500539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy.
    Wang X; Zhang L; Du J; Wei Y; Wang D; Song C; Chen D; Li B; Jiang M; Zhang M; Zhao H; Kong Y
    Front Immunol; 2022; 13():869286. PubMed ID: 35444646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Abnormal Activation of T Cells in HIV-1 Infection After Antiretroviral Therapy].
    Guo Y; Zhang YL; Zhu D; Gong FH; Gao YS; Zhu KR; Li SS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):415-421. PubMed ID: 36949708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase-1-Mediated Pyroptosis of the Predominance for Driving CD4[Formula: see text] T Cells Death: A Nonlocal Spatial Mathematical Model.
    Wang W; Zhang T
    Bull Math Biol; 2018 Mar; 80(3):540-582. PubMed ID: 29349609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M; Cordero M; Almeida J; Orfao A
    Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Peripheral T Follicular Helper Cells in Perinatally HIV-Infected Children Correlate With Advancing HIV Disease.
    McCarty B; Mwamzuka M; Marshed F; Generoso M; Alvarez P; Ilmet T; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A
    Front Immunol; 2018; 9():1901. PubMed ID: 30197641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.
    Körner C; Krämer B; Schulte D; Coenen M; Mauss S; Fätkenheuer G; Oldenburg J; Nattermann J; Rockstroh JK; Spengler U
    Clin Sci (Lond); 2009 May; 116(12):861-70. PubMed ID: 19128241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
    d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
    PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Analysis of Peripheral and Colonic CD161
    Lal KG; Phuang-Ngern Y; Suhkumvittaya S; Leeansyah E; Alrubayyi A; Dias J; Waickman A; Kim D; Kroon E; Pinyakorn S; Eller LA; Maciel M; Rerknimitr R; Chomchey N; Phanuphak N; de Souza MSS; Nitayaphan S; Ake JA; Vasan S; Robb ML; Ananworanich J; Sandberg JK; Schuetz A; Eller MA; Paquin-Proulx D
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.